 Conformis, Inc. CFMS, a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patients unique anatomy, today announced preliminary, unaudited, revenue results for the second quarter ended June 30, 2020. As expected, the second quarter was impacted by the novel coronavirus COVID-19 pandemic, said Mark Augusti, President and Chief Executive Officer. 